Form 8-K VEEVA SYSTEMS INC For: May 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Veeva Systems (VEEV) PT Raised to $304 at BofA Securities
May 29, 2025 5:38 AM EDTBofA Securities analyst Brad Sills raised the price target on Veeva Systems (NYSE: VEEV) to $304.00 (from $254.00) while maintaining a Neutral rating.
The analyst comments "Veeva reported a strong start to FY26, with subscription revenue and normalized billings of $635 million (+19% y/y) and $714... More
Veeva Systems (VEEV) PT Raised to $295 at Stifel
May 29, 2025 5:05 AM EDTStifel analyst David Grossman raised the price target on Veeva Systems (NYSE: VEEV) to $295.00 (from $272.00) while maintaining a Buy rating.
The analyst comments "F1Q revenue significantly outperformed (subscription revenue +19%, +17% total revenue growth), which translated to meaningful billings/margin/EPS outperformance. Both subscription (+19% y/y, 85% of... More
Veeva Systems (VEEV) PT Raised to $210 at Morgan Stanley
May 29, 2025 5:02 AM EDTMorgan Stanley analyst Craig Hettenbach raised the price target on Veeva Systems (NYSE: VEEV) to $210.00 (from $201.00) while maintaining a Underweight rating.
The analyst comments "Why stay Underweight? Veeva deserves credit for navigating through a tumultuous backdrop in Life Sciences that has tripped up... More
